The antagonism by naloxone of agents that interact with dopaminergic neurones.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D002047:Buprenorphine / Q000037:antagonists & inhibitors; D003913:Dextroamphetamine / Q000037:antagonists & inhibitors; D004298:Dopamine / Q000378:metabolism*; D006220:Haloperidol / Q000494:pharmacology; D006719:Homovanillic Acid / Q000378:metabolism; D008781:Methyltyrosines / Q000494:pharmacology; D009020:Morphine / Q000037:antagonists & inhibitors; D009270:Naloxone / Q000494:pharmacology*; D009474:Neurons / Q000187:drug effects; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats
D008781:Methyltyrosines; D009270:Naloxone; D002047:Buprenorphine; D009020:Morphine; D006220:Haloperidol; D003913:Dextroamphetamine; D004298:Dopamine; D009638:Norepinephrine; D006719:Homovanillic Acid